Lantern Pharma Inc.
(LTRN)
undefined
undefined%
At close: undefined
3.32
-4.18%
Pre-market Dec 16, 2024, 08:03 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -15.96M | -14.26M | -12.36M | -5.91M | -2.43M | -1.73M |
| Depreciation & Amortization | 14.62K | 10.08K | 6.76K | 3.39K | 1.63K | -2.54K |
| Stock-Based Compensation | 1.07M | 1.19M | 961.54K | 1.19M | 117.76K | 185.60K |
| Other Working Capital | 538.02K | -1.03M | -950.47K | -1.06M | -191.79K | 271.84K |
| Other Non-Cash Items | -5.17K | 906.49K | 90.66K | 1.08M | -251.65K | -76.32K |
| Deferred Income Tax | - | - | 112.56K | -1.08M | 251.65K | - |
| Change in Working Capital | 538.02K | -611.86K | 599.96K | -939.06K | 180.88K | 271.84K |
| Operating Cash Flow | -14.35M | -12.77M | -10.59M | -5.65M | -2.13M | -1.27M |
| Capital Expenditures | -18.73K | -27.84K | -15.50K | -16.14K | -5.72K | - |
| Acquisitions | - | -179.27M | 19.53B | - | - | 5.34K |
| Purchase of Investments | - | -3.91M | -19.58M | - | - | - |
| Sales Maturities Of Investments | 7.28M | 4.12M | 64.09K | - | - | - |
| Other Investing Acitivies | -8.20M | 179.27M | -19.53B | -5.72M | - | 5.34K |
| Investing Cash Flow | -930.21K | 179.27K | -19.53M | -16.14K | -5.72K | 5.34K |
| Debt Repayment | - | - | - | 108.50K | - | - |
| Common Stock Repurchased | -500.00K | -2.48M | -939.67K | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | - | -2.48M | -5.58M | 26.25M | 2.92M | 535.00K |
| Financial Cash Flow | -500.00K | -2.18K | 63.42M | 23.66M | 2.92M | 535.00K |
| Net Cash Flow | -15.81K | -14.78M | 33.30M | 18.00M | 786.87K | -731.18K |
| Free Cash Flow | -14.37M | -12.80M | -10.61M | -5.67M | -2.13M | -1.27M |